BioCentury
ARTICLE | Finance

IPO watch

Endocyte, Pacira prepare to be early 2011 biotech IPOs

January 17, 2011 8:00 AM UTC

After filling in offering details in their S-1s last week, oncology company Endocyte Inc. and specialty pain play Pacira Pharmaceuticals Inc. may be among the first IPOs of the year.

Endocyte hopes to sell 5.4 million shares at $13-$15. A $14 price would raise $74.9 million and value the company at $269.3 million. In August 2010, the company filed to raise up to $86.3 million...